IMI Fondi Chiusi backs Svas Biosana

IMI Fondi Chiusi, the private equity and venture capital branch of Intesa Sanpaolo Group, made the investment through the €200m Atlante Private Equity vehicle, launched in 2009.

The investment will underpin Svas Biosana's national and international growth, with future acquisitions under consideration.

Company
Founded in 1970 and based in Naples, Svas Biosana operates in the medical devices sector and sells infusion solutions.

The firm has over 200 employees and a €47m turnover.

People
Antonio Finocchi Ghersi is a senior partner at IMI Fondi Chiusi, while Antonio Riccio is an investment director. Umberto Perillo is managing director of Svas Biosana.

Advisers
Equity – PricewaterhouseCoopers (Corporate finance); Ughi e Nunziante, Roberto Leccese (Legal).
Company – CFMP, Attilio Ferrari, Andrea Pedeferri (Legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Southern Europe
• Healthcare
• Expansion
• Italy
• Intesa Sanpaolo